Company
Azalea Therapeutics
Redefining precision genomic medicines, in vivo
Also known as Azalea Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Azalea Therapeutics, Inc.
- azaleatx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Azalea Therapeutics is enabling precision genome engineering directly inside the body, with an initial focus on creating cancer immunotherapies in vivo.
Funding snapshot
- Total raised
- $82MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $82M2025-11-04
Funding rounds
- Round, 2025
- $82M2025-11-04, Company stated
Loading relationship preview